Sleep Centers: Expand Your Testing Platform
with AccuSom Deliver

With over 15 million undiagnosed Obstructive Sleep Apnea patients in the U.S., there is an opportunity for innovative Sleep Centers to identity more OSA sufferers and improve their health through the adoption of Out of Center Sleep Testing (OCST). In certain markets, payers are requiring the use of OCST for uncomplicated adult OSA. Consequently, a high-quality, accurate, scalable and cost-effective OCST solution is necessary for many Centers wishing to expand their reach.

• Requires no fixed charges or capital investment in devices or disposables
• Is turnkey with minimal burden on your staff
• Matches your fluctuating OCST volume -- no excess device inventory and no shortages
• Eliminates the need for device and disposables inventory management
• Provides FDA- cleared and Joint Commission accredited manufacturing, service, HIPAA compliance and quality assurance processes through a Medicare-certified IDTF
• Is appropriate for any payer
• Allows you to maintain control of face to face patient interaction, interpretations, and payer/patient billing.

The NovaSom solution includes our state-of-the-art wireless AccuSom device, a CMS Type III, AASM-compliant device, which directly captures the parameters required to diagnose OSA (respiratory effort, airflow, heart rate, oxymetry and snoring) . The AccuSom is the only FDA cleared wireless OCST device, enabling Sleep Centers to interpret results the same day the test is completed. Its wireless functionality also allows early patient outreach if testing does not commence when scheduled, improving compliance and reducing the time to titration and therapy.